ADRB1
adrenergic, beta-1-, receptor
ADRB1; adrenergic, beta-1-, receptor; beta-1 adrenergic receptor; ADR B1; ADRB 1; ADRB1_HUMAN; ADRB1R; Adrenergic beta 1 receptor; B1AR; Beta 1 adrenoceptor; Beta 1 adrenoreceptor; Beta-1 adrenoceptor; Beta-1 adrenoreceptor; BETA1AR; RHR;
CD86
Cluster of Differentiation 86
Cluster of Differentiation 86; CD86; B7-2; B7.2; B70; CD28LG2; LAB72; MGC34413; T-lymphocyte activation antigen CD86; BU63; FUN-1; B7-2 antigen; OTTHUMP00000215511; OTTHUMP00000215512; OTTHUMP00000215513; OTTHUMP00000215514; OTTHUMP00000215515; CD28 antigen ligand 2; activation B7-2 antigen; CTLA-4 counter-receptor B7.2; B-lymphocyte activation antigen B7-2; CD86 antigen (CD28 antigen ligand 2, B7-2 antigen);
EDF1
endothelial differentiation-related factor 1
EDF1; endothelial differentiation-related factor 1; EDF 1; multiprotein bridging factor 1; MBF1; EDF-1; MGC9058;
GDF10
growth differentiation factor 10
GDF10; growth differentiation factor 10; bone morphogenetic protein 3B; BMP 3b; BIP; GDF-10; bone-inducing protein; BMP3B; BMP-3b;
GDF11
growth differentiation factor 11
GDF11; growth differentiation factor 11; growth/differentiation factor 11; BMP 11; GDF-11; bone morphogenetic protein 11; BMP11; BMP-11;
GDF15
growth differentiation factor 15
GDF15; growth differentiation factor 15; PDF; MIC1; PLAB; MIC-1; NAG-1; PTGFB; GDF-15; growth/differentiation factor 15; NRG-1; PTGF-beta; placental TGF-beta; NSAID-activated gene 1 protein; NSAID-regulated gene 1 protein; prostate differentiation factor; macrophage inhibitory cytokine 1; placental bone morphogenetic protein; NSAID (nonsteroidal anti-inflammatory drug)-activated protein 1;
GDF2
growth differentiation factor 2
BMP-9; BMP9; GDF2; growth differentiation factor 2; GDF-2; bone morphogenetic protein 9; growth/differentiation factor 2; Human BMP9 ELISA KIT; Human; BMP9 ELISA KIT; ELISA KIT; BMP9 ELISA; KIT; ELISA;
GDF3
growth differentiation factor 3
GDF3; growth differentiation factor 3; KFS3; MCOP7; MCOPCB6; growth/differentiation factor 3; GDF-3;
GDF5
growth differentiation factor 5
GDF5; growth differentiation factor 5; growth/differentiation factor 5; BMP14; cartilage derived morphogenetic protein 1; CDMP1; GDF-5; CDMP-1; radotermin; cartilage-derived morphogenetic protein-1; OS5; LAP4; SYNS2;
GDF6
growth differentiation factor 6
GDF6; growth differentiation factor 6; growth/differentiation factor 6; BMP13; GDF-6; Klippel-Feil syndrome; Klip-Feil malformation; Klippel-Feil malformation; growth/differentiation factor 16; KFM; KFS; KFS1; KFSL; SGM1; CDMP2; MCOP4; SCDO4; MCOPCB6; MGC;
GDF9
growth differentiation factor 9
GDF9; growth differentiation factor 9; growth/differentiation factor 9; GDF-9;
MNDA
myeloid cell nuclear differentiation antigen
MNDA; myeloid cell nuclear differentiation antigen; PYHIN3;
MYD88
myeloid differentiation primary response 88
MYD88; myeloid differentiation primary response 88; MYD88D; myeloid differentiation primary response protein MyD88; myeloid differentiation primary response gene (88);
MYOD1
myogenic differentiation 1
MyoD; MYOD1; MYF3; MYOD; PUM; bHLHc1; myogenic differentiation 1; myoblast determination protein 1; myf-3; myogenic factor 3; class C basic helix-loop-helix protein 1;
REN
renin
Prorenin; REN; renin; angiotensinogenase; renin precursor, renal; angiotensin-forming enzyme; HNFJ2; FLJ10761;
Ren1
Renin 1 Structural
Ren1; renin 1 structural; Ren; Rnr; Rn-1; Ren-1; Ren-A; Ren1c; Ren1d; D19352; renin-1; renin b; kidney renin; aspartyl-protease; OTTMUSP00000024128; angiotensinogenase; renin; EC 3.4.23.15; renin precursor, renal; HNFJ2; FLJ107612; EC 3.4.238; angiotensin-forming enzyme; Prorenin; FLJ10761; RENAA; Renin precursor renal; Angiotensin forming enzyme;
RQCD1
RCD1 required for cell differentiation1 homolog
RQCD1; RCD1 required for cell differentiation1 homolog (S. pombe); rcd1 (required for cell differentiation, S.pombe) homolog 1; cell differentiation protein RCD1 homolog; cancer/testis antigen 129; CNOT9; CT129; RCD1; RCD1+; rcd-1; protein involved in sex;
SSB
Sjogren syndrome antigen B (autoantigen La)
La; LARP3; La/SSB; La/SSB (Autoimmune RNA Protein); SSB; Sjogren syndrome antigen B (autoantigen La);
AAAS
achalasia, adrenocortical insufficiency, alacrimia
AAAS; achalasia, adrenocortical insufficiency, alacrimia; achalasia, adrenocortical insufficiency, alacrimia (Allgrove, triple A); aladin; Allgrove; triple A; Allgrove, triple-A; AAA; AAASb; GL003; ADRACALA; ADRACALIN; DKFZp586G1624;
ACD
adrenocortical dysplasia homolog (mouse)
ACD; adrenocortical dysplasia homolog (mouse); adrenocortical dysplasia protein homolog; Pip1; POT1 and TIN2 organizing protein; Ptop; TIN2 interacting protein 1; Tint1; Tpp1; POT1 and TIN2-interacting protein;
ADRA1A
adrenergic, alpha-1A-, receptor
ADRA1A; adrenergic, alpha-1A-, receptor; alpha-1A adrenergic receptor; ADA1A_HUMAN; Adra1c; ADRA1L1; Adrenergic alpha1A receptor; Adrenergic alpha1C receptor; Adrenergic receptor alpha 1a; Adrenergic receptor alpha 1c; Alpha 1A adrenoreceptor; Alpha 1C adrenergic receptor; Alpha-1A adrenoceptor; Alpha-1A adrenoreceptor; Alpha-1C adrenergic receptor; Alpha-adrenergic receptor 1c; Alpha1A adrenergic receptor; ALPHA1AAR; alpha 1A-adrenoceptor; alpha 1A-adrenoreceptor; adrenergic, alpha 1A, receptor; adrenergic, alpha 1C, receptor;
ADRBK1
adrenergic, beta, receptor kinase 1
ADRBK1; adrenergic, beta, receptor kinase 1; beta-adrenergic receptor kinase 1; BARK1; GRK2; beta-ARK-1; G-protein coupled receptor kinase 2; BETA-ARK1; FLJ16718;
GDF7
growth differentiation factor 7
GDF7; growth differentiation factor 7; growth/differentiation factor 7; BMP12; bone morphogenetic protein 12; GDF-7; GDF7_HUMAN; OTTHUMP00000115986;
KYNU
kynureninase
KYNU; kynureninase; kynureninase (L kynurenine hydrolase); L kynurenine hydrolase; kynureninase (L-kynurenine hydrolase); L-kynurenine hydrolase; OTTHUMP00000162647; OTTHUMP00000204304; OTTHUMP00000204305; 4432411A05Rik;
NEUROD1
neuronal differentiation 1
NEUROD1; neuronal differentiation 1; NEUROD, neurogenic differentiation 1; neurogenic differentiation factor 1; beta cell E box transactivator 2; BETA2; BHF 1; bHLHa3; MODY6; NeuroD; neurogenic helix loop helix protein NEUROD; beta-cell E-box transactiva;
NEUROD6
neurogenic differentiation 6
NEUROD6; neurogenic differentiation 6; neurogenic differentiation factor 6; Atoh2; bHLHa2; Math 2; NEX1M; Atoh 2; Atonal homolog 2; Atonal protein homolog 2; Atonal protein homolog2; bHLH a2; bHLHa 2; Class A basic helix-loop-helix protein 2; Helix loop helix protein mATH 2; Helix loop helix protein mATH2; Math2; NDF 6; NDF6; NDF6_HUMAN; Neuro D6; Nex 1; Nex 1m; Nex; Nex1; Nex1 m; Protein atonal homolog 2; Protein atonal homolog2; OTTHUMP00000123444; Math-2;
NODAL
nodal growth differentiation factor
NODAL; nodal growth differentiation factor; HTX5; nodal homolog;
OCRL
oculocerebrorenal syndrome of Lowe
OCRL; oculocerebrorenal syndrome of Lowe; inositol polyphosphate 5-phosphatase OCRL-1; OCRL1; Lowe oculocerebrorenal syndrome protein; phosphatidylinositol polyphosphate 5-phosphatase; LOCR; NPHL2; INPP5F; OCRL-1;
OPHN1
oligophrenin 1
OPHN1; oligophrenin 1; mental retardation, X linked 60 , MRX60; oligophrenin-1; ARHGAP41; OPN1; OTTHUMP00000023451; mental retardation, X-linked 60; oligophrenin-1, Rho-GTPase activating protein; MRX60;
ROD1
ROD1 regulator of differentiation 1 (S. pombe)
ROD1; ROD1 regulator of differentiation 1 (S. pombe); regulator of differentiation (in S. pombe) 1; regulator of differentiation 1; PTBP3; DKFZp781I1117; Fission yeast differentiation regulator; ROD 1; ROD1 regulator of differentiation 1; ROD1_HUMAN; OTTHUMP00000021931; OTTHUMP00000021932; OTTHUMP00000021933;
SSSCA1
Sjogren syndrome/scleroderma autoantigen 1
SSSCA1; Sjogren syndrome/scleroderma autoantigen 1; Sjogrens syndrome/scleroderma autoantigen 1; Sjoegren syndrome/scleroderma autoantigen 1; p27; Autoantigen p27; 1500016H19Rik; C184L; centromeric autoantigen (27kD); OTTHUMP00000232769; OTTHUMP00000233069; OTTHUMP00000233071; Sjogrens syndrome/scleroderma autoantigen 1 homolog; SSA27_HUMAN;
COQ2
coenzyme Q2 homolog, prenyltransferase (yeast)
COQ2; coenzyme Q2 homolog, prenyltransferase (yeast); 4-hydroxybenzoate polyprenyltransferase, mitochondrial; 4 hydroxybenzoate polyprenyltransferase; CL640; FLJ26072; MGC91278; 2310002F18Rik; FLJ13014; hCOQ2; MGC124824; OTTMUSP00000032111; Para-hydroxybenzoate--polyprenyltransferase, mitochondrial; PHB:polyprenyltransferase; RGD1306722; COQ2 homolog; para-hydroxybenzoate-polyprenyltransferase, mitochondrial;
DEF6
differentially expressed in FDCP 6 homolog (mouse)
DEF6; differentially expressed in FDCP 6 homolog (mouse); differentially expressed in FDCP (mouse homolog) 6; differentially expressed in FDCP 6 homolog; IBP; SLAT; SWAP 70 like adaptor protein of T cells; SWAP70L; DEF-6; IRF4-binding protein; SWAP-70-lik;
EID1
EID1 EP300 interacting inhibitor of differentiation 1
EID1; EP300 interacting inhibitor of differentiation 1; C15orf3, CREBBP/EP300 inhibitor 1 , CREBBP/EP300 inhibitory protein 1 , CRI1; EP300-interacting inhibitor of differentiation 1; EID 1; CREBBP/EP300 inhibitor 1; 21 kDa pRb-associated protein; NB4 apoptosis related protein; CREBBP/EP300 inhibitory protein 1; Rb- and p300-binding protein EID-1; E1A-like inhibitor of differentiation 1; retinoblastoma protein-associated protein; CRI1; EID-1; RBP21; PTD014; C15orf3; PNAS-22; IRO45620; MGC138883; MGC138884;
PCYOX1
prenylcysteine oxidase 1
PCYOX1; prenylcysteine oxidase 1; KIAA0908; PCL1; EC 1.8.3.5; Prenylcysteine lyase; Prenylcysteine oxidase precursor; OTTHUMP00000160077; OTTHUMP00000204091; OTTHUMP00000204094;
RAGE
renal tumor antigen
RAGE; renal tumor antigen; renal tumor antigen; MOK protein kinase; MOK; MAPK/MAK/MRK overlapping kinase; renal cell carcinoma antigen (MOK protein kinase); Renal tumor antigen 1; EC 2.7.11.22; RAGE1; RAGE-1; OTTHUMP00000227853; OTTHUMP00000227854; OTTHUMP00000227855;
RCE1
RCE1 homolog, prenyl protein protease (S. cerevisiae)
RCE1; RCE1 homolog, prenyl protein protease (S. cerevisiae); RCE1 (S. Cerevisiae) homolog, prenyl protein protease , RCE1 homolog, prenyl protein peptidase (S. cerevisiae) , RCE1A, RCE1B; CAAX prenyl protease 2; FACE 2; FACE2; farnesylated protein converting enzyme 2; hRCE1; prenyl protein specific endoprotease 2; RCE1 homolog; prenyl protein protease; RCE1 homolog, prenyl protein peptidase; prenyl protein-specific endoprotease 2; farnesylated protein-converting enzyme 2; farnesylated proteins-converting enzyme 2; RCE1A; RCE1B;
WBSCR22
Williams Beuren syndrome chromosome region 22
WBSCR22; Williams Beuren syndrome chromosome region 22; uncharacterized methyltransferase WBSCR22; MGC2022; MGC5140; MGC19709; PP3381; WBMT; HASJ4442; HUSSY 3; HUSSY3; WBS22_HUMAN; Williams Beuren candidate region putative methyltransferase; Williams Beuren syndrome chromosome region 22 protein; Williams-Beuren syndrome chromosomal region 22 protein; Williams-Beuren candidate region putative methyltransferase; HUSSY-3;
ADRBK2
adrenergic, beta, receptor kinase 2
ADRBK2; adrenergic, beta, receptor kinase 2; beta-adrenergic receptor kinase 2; BARK2; GRK3; beta-ARK-2; G-protein-coupled receptor kinase 3;
IHOG
interference Hedgehog
IHOG; interference Hedgehog; CG9211 gene product from transcript CG9211-RA; Dmel\CG9211; DmelCG9211; CG9211; CG9211 PA; CT26314; iHog PA; CG9211-PA; iHog-PA; interference hedghog;
MYADM
myeloid-associated differentiation marker
MYADM; myeloid-associated differentiation marker; myeloid upregulated protein; SB135;
SSNA1
Sjogren syndrome nuclear autoantigen 1
SSNA1; Sjogren syndrome nuclear autoantigen 1; Sjogrens syndrome nuclear autoantigen 1; Sjoegren syndrome nuclear autoantigen 1; N14; NA14; NA 14; Nuclear autoantigen of 14 kDa; SSNA 1; OTTHUMP00000022691; NA-14;
ADRB2
adrenoceptor beta 2, surface
ADRB2; adrenoceptor beta 2, surface; BAR; B2AR; ADRBR; ADRB2R; BETA2AR; beta-2 adrenergic receptor; beta-2 adrenoceptor; beta-2 adrenoreceptor; catecholamine receptor; adrenoceptor beta 2 surface; adrenergic, beta-2-, receptor, surface;
RENBP
renin binding protein
RENBP; renin binding protein; RBP; RNBP; N-acylglucosamine 2-epimerase; AGE; GlcNAc 2-epimerase; N-acetyl-D-glucosamine 2-epimerase;
ADRB3
adrenergic receptor, beta 3
ADRB3; adrenergic receptor, beta 3; beta-3 adrenergic receptor; ADR B3; ADRB 3; ADRB3_HUMAN; ADRB3R; Adrenergic beta 3 receptor; B3AR; Beta 3 adrenoceptor; Beta 3 adrenoreceptor; Beta 3AR; Beta-3 adrenoceptor; Beta-3 adrenoreceptor; Beta3AR; FLJ99960; Beta-3 AR; beta 3-AR; OTTMUSP00000036279; beta3-adrenergic receptor; Adrb-3;
DISC1
disrupted in schizophrenia 1
DISC1; disrupted in schizophrenia 1; disrupted in schizophrenia 1 protein; SCZD9; C1orf136; FLJ13381; FLJ21640; FLJ25311; FLJ41105; KIAA0457;
ADRA1B
adrenergic, alpha-1B-, receptor
ADRA1B; adrenergic, alpha-1B-, receptor; alpha-1B adrenergic receptor; alpha-1B adrenoceptor; alpha-1B adrenoreceptor; alpha-1B-adrenergic receptor; ADRA1; ALPHA1BAR;
ADRA2B
adrenergic receptor, alpha 2b
ADRA2B; adrenergic receptor, alpha 2b; alpha-2B adrenergic receptor; alpha-2BAR; subtype alpha2-C2; alpha-2B adrenoceptor; alpha-2B adrenoreceptor; [a]2B; Adra-2b; alpha2B; alpha2-C2;
EID3
EP300 interacting inhibitor of differentiation 3
EID3; EP300 interacting inhibitor of differentiation 3; EP300-interacting inhibitor of differentiation 3; FLJ25832; NSE4B; NSMCE4B; E1A-like inhibitor of differentiation 3; EID 3; EID-1-like inhibitor of differentiation 3; Non-SMC element 4, S. cerevisiae, homolog of, B; EID-3;
ICMT
isoprenylcysteine carboxyl methyltransferase
ICMT; isoprenylcysteine carboxyl methyltransferase; protein-S-isoprenylcysteine O-methyltransferase; HSTE14; PCCMT; PPMT; protein S isoprenylcysteine O methyltransferase; 1700008E11Rik; C80758; fcmt; Gm13095; MGC118506; OTTMUSG00000010406; ICMT_HUMAN; Isoprenylcysteine carboxylmethyltransferase; MGC39955; MGC95322; MST098; MSTP098; PCMT; Prenylated protein carboxyl methyltransferase; Prenylcysteine carboxyl methyltransferase; RP23-421E12.4; STE14; protein-S isoprenylcysteine O-methyltransferase;
PDSS1
prenyl (decaprenyl) diphosphate synthase, subunit 1
PDSS1; prenyl (decaprenyl) diphosphate synthase, subunit 1; TPRT, trans prenyltransferase; decaprenyl-diphosphate synthase subunit 1; coenzyme Q1 homolog (yeast); COQ1; TPT; coenzyme Q1 homolog; trans-prenyltransferase 1; trans-prenyltransferase (TPT); p;
GDAP1
ganglioside-induced differentiation-associated protein 1
GDAP1; ganglioside-induced differentiation-associated protein 1; Charcot Marie Tooth neuropathy 4A , CMT4A; CMT4; Ganglioside induced differentiation associated protein 1; GDAP1_HUMAN; OTTHUMP00000226874; OTTHUMP00000226875; Charcot-Marie-Tooth neuropathy 4A; ganglioside differentiation associated protein 1; CMT4A; CMTRIA;
GDAP2
ganglioside induced differentiation associated protein 2
GDAP2; ganglioside induced differentiation associated protein 2; ganglioside-induced differentiation-associated protein 2; dJ776P7.1; FLJ20142; MACROD3;
MAL2
mal, T-cell differentiation protein 2
MAL2; mal, T-cell differentiation protein 2; protein MAL2; MAL 2; MAL proteolipid protein 2; Mal, T cell differentiation protein 2; MAL2_HUMAN; AI461653;
MALL
mal, T-cell differentiation protein-like
MALL; mal, T-cell differentiation protein-like; MAL-like protein; BENE; MAL like protein; mal T cell differentiation protein like; Protein BENE;
ISPD
isoprenoid synthase domain containing
ISPD; isoprenoid synthase domain containing; 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein; 4 diphosphocytidyl 2C methyl D erythritol synthase homolog (Arabidopsis); hCG_1745121; Nip; notch1 induced protein; Isoprenoid synthase domain-containing protein; ISPD_HUMAN; notch1-induced protein; 4-diphosphocytidyl-2C-methyl-D-erythritol synthase homolog;
KCTD11
potassium channel tetramerisation domain containing 11
KCTD11; potassium channel tetramerisation domain containing 11; C17orf36, chromosome 17 open reading frame 36; BTB/POZ domain-containing protein KCTD11; KCASH1; REN; C 17 orf 36; C17orf36; MGC 129844; Retinoic acid EGF NGF induced gene protein; retinoic acid, EGF, NGF induced gene protein; potassium channel tetramerization domain containing 11; retinoic acid, EGF, NGF induced gene/potassium channel tetramerization domain containing 11; REN/KCTD11;
KMO
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase)
KMO; kynurenine 3-monooxygenase (kynurenine 3-hydroxylase); kynurenine 3-monooxygenase; dJ317G22.1; Kynurenine 3 hydroxylase; Kynurenine 3 monooxygenase (kynurenine 3 hydroxylase); Kynurenine 3 monooxygenase; RP1-317G22.1; kynurenine 3-hydroxylase; AI046660;
PRCC
papillary renal cell carcinoma (translocation-associated)
PRCC; papillary renal cell carcinoma (translocation-associated); proline-rich protein PRCC; RCCP1; papillary renal cell carcinoma translocation-associated gene protein; TPRC; MGC4723; MGC17178;
METRN
meteorin, glial cell differentiation regulator
METRN; meteorin, glial cell differentiation regulator; C16orf23, chromosome 16 open reading frame 23; meteorin; MGC2601; Meteorin precursor; METRN_HUMAN; C16orf23; c380A1.2;
MMD
monocyte to macrophage differentiation-associated
MMD; monocyte to macrophage differentiation-associated; monocyte to macrophage differentiation protein; MMA; PAQR11; 1810073C06Rik; AA690185; 1200017E07Rik; Maf; MGC94095; OTTMUSP00000001266; OTTMUSP00000001267; Progestin and adipoQ receptor family member 11; Progestin and adipoQ receptor family member XI; RP23-220F20.1; macrophage maturation-associated;
MMD2
monocyte to macrophage differentiation-associated 2
MMD2; monocyte to macrophage differentiation-associated 2; monocyte to macrophage differentiation factor 2; PAQR10; FLJ37205; MMD 2; Monocyte to macrophage differentiation associated 2; Progestin and adipoQ receptor family member X; progestin and adipoQ receptor family member 10; monocyte-to-macrophage differentiation factor 2;
NEUROD4
neurogenic differentiation 4
NEUROD4; neurogenic differentiation 4; neurogenic differentiation factor 4; ATH 3; Atoh3; bHLHa4; MATH 3; ATH3; Protein atonal homolog 3; class A basic helix-loop-helix protein 4; ATH-3; MATH-3;
PRR5
proline rich 5 (renal)
PRR5; proline rich 5 (renal); PP610; PROTOR1; PROTOR-1; FLJ20185k; proline-rich protein 5; protein observed with Rictor-1; Rho GTPase activating protein 8;
NRSN2
neurensin 2
NRSN2; neurensin 2; C20orf98, chromosome 20 open reading frame 98; neurensin-2; dJ1103G7.6; C20orf98; NRSN 2; NRSN2_HUMAN;
PDSS2
prenyl (decaprenyl) diphosphate synthase, subunit 2
PDSS2; prenyl (decaprenyl) diphosphate synthase, subunit 2; C6orf210, chromosome 6 open reading frame 210; decaprenyl-diphosphate synthase subunit 2; bA59I9.3; C6orf210; Candidate tumor suppressor protein; chromosome 6 open reading frame 210; decaprenyl pyrophosphate synthetase subunit 2; DLP1; hDLP1; subunit 2 of decaprenyl diphosphate synthase; decaprenyl pyrophosphate synthase subunit 2; all-trans-decaprenyl-diphosphate synthase subunit 2;
RNLS
renalase, FAD-dependent amine oxidase
RNLS; renalase, FAD-dependent amine oxidase; C10orf59, chromosome 10 open reading frame 59; renalase; FLJ11218; 6530404N21Rik; mMAO C; AI452315; AW060440; C10orf59; Chromosome 10 open reading frame 59; HGNC:25641; Hypothetical protein LOC55328; MAO C; Monoamine oxidase C; Renalase, FAD dependent amine oxidase; MAO-C; monoamine oxidase-C;
PRAME
preferentially expressed antigen in melanoma
PRAME; preferentially expressed antigen in melanoma; MAPE; melanoma antigen preferentially expressed in tumors; cancer/testis antigen 130; CT130; 4930534P07Rik; OIP 4; OIP-4; OIP4; OPA interacting protein 4; Opa interacting protein OIP4; OPA-interacting protein 4; PRAME_HUMAN; Preferentially expressed antigen of melanoma; RP23-250F8.3; Opa-interacting protein OIP4;
PTAR1
protein prenyltransferase alpha subunit repeat containing 1
PTAR1; protein prenyltransferase alpha subunit repeat containing 1; protein prenyltransferase alpha subunit repeat-containing protein 1; 4930428J16Rik; FLJ45604;
SYNDIG1L
synapse differentiation inducing 1-like
SYNDIG1L; synapse differentiation inducing 1-like; TMEM90A, transmembrane protein 90A; synapse differentiation-inducing gene protein 1-like; capucin; caudate and putamen enriched sequence; IFITMD4; interferon induced transmembrane protein domain containing 4; TM90A_HUMAN; tmem90a; Transmembrane protein 90A; caudate-and putamen-enriched sequence; caudate- and putamen-enriched sequence;
UTF1
undifferentiated embryonic cell transcription factor 1
UTF1; undifferentiated embryonic cell transcription factor 1;
UBIAD1
UbiA prenyltransferase domain containing 1
UBIAD1; UbiA prenyltransferase domain containing 1; SCCD, Schnyder crystalline corneal dystrophy; ubiA prenyltransferase domain-containing protein 1; TERE1; transitional epithelia response protein; transitional epithelial response protein 1; SCCD; RP4-79;
WBSCR16
Williams-Beuren syndrome chromosome region 16
WBSCR16; Williams-Beuren syndrome chromosome region 16; Williams-Beuren syndrome chromosomal region 16 protein; 5730496C04Rik; MGC44931; AU019812; DKFZp434D0421; MGC189739; RCC1-like G exchanging factor-like protein; WBS16_HUMAN;
VEZT
vezatin, adherens junctions transmembrane protein
VEZT; vezatin, adherens junctions transmembrane protein; vezatin; DKFZP761C241;
WBSCR27
Williams Beuren syndrome chromosome region 27
WBSCR27; Williams Beuren syndrome chromosome region 27; Williams-Beuren syndrome chromosomal region 27 protein; MGC40131;
ADRA2C
adrenergic, alpha-2C-, receptor
ADRA2C; adrenergic, alpha-2C-, receptor; ADRA2L2, ADRA2RL2; alpha-2C adrenergic receptor; ADRARL2; alpha-2CAR; alpha2-AR-C4; alpha-2C adrenoceptor; alpha-2C adrenoreceptor; alpha-2C-adrenergic receptor; alpha-2 adrenergic receptor subtype C4; ADRA2L2; ADR;
NUS1
nuclear undecaprenyl pyrophosphate synthase 1 homolog
NUS1; nuclear undecaprenyl pyrophosphate synthase 1 homolog (S. cerevisiae); C6orf68, chromosome 6 open reading frame 68; nogo-B receptor; MGC7199; NgBR; C6orf68; MGC:7199; MGC117249;
GDF1
growth differentiation factor 1
GDF1; growth differentiation factor 1; embryonic growth/differentiation factor 1; GDF-1; DORV; DTGA3;
NPDC1
neural proliferation, differentiation and control, 1
NPDC1;neural proliferation, differentiation and control, 1;7899;ENSG00000107281;CAB;CAB-;CAB1;CAB-1;NPDC-1;9q34.3;DKFZp586J0523;neural proliferation differentiation and control protein 1;neural proliferation differentiation and control protein 1;
METRNL
meteorin, glial cell differentiation regulator-like
METRNL;meteorin, glial cell differentiation regulator-like;27584;ENSG00000176845;17q25.3;MGC99788;meteorin-like protein;meteorin-like protein;
WBSCR17
Williams-Beuren syndrome chromosome region 17
WBSCR17;Williams-Beuren syndrome chromosome region 17;16347;ENSG00000185274;GALNT16;GALNT20;GALNTL3;7q11.23;DKFZp434I2216, DKFZp761D2324;putative polypeptide N-acetylgalactosaminyltransferase-like protein 3;putative polypeptide N-acetylgalactosaminyltransferase-like protein 3;galNAc-T-like protein 3;pp-GalNAc-transferase 20;pp-GaNTase-like protein 3;polypeptide GalNAc transferase-like protein 3;polypeptide N-acetylgalactosaminyltransferase WBSCR17;williams-Beuren syndrome chromosomal region 17 protein;protein-UDP acetylgalactosaminyltransferase-like protein 3;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like 3;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 3;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 16;EC 2.4.1.41;
ADRA1D
adrenoceptor alpha 1D
ADRA1D;adrenoceptor alpha 1D;280;ENSG00000171873;DAR;ADRA1;ADRA1A;ADRA1R;ALPHA1;dJ779E11.2;20p13;alpha-1D adrenergic receptor;alpha-1D adrenergic receptor;alpha-1D adrenoceptor;alpha-1D adrenoreceptor;alpha-1A adrenergic receptor;alpha-1D-adrenergic receptor;alpha-adrenergic receptor 1a;adrenergic, alpha-1A-, receptor;adrenergic, alpha-1D-, receptor;adrenergic, alpha -1D-, receptor;
ADRA2A
Adrenergic, Alpha-2A-, Receptor
Adra2a; adrenergic, alpha-2A-, receptor; RG20; CA2-47; RATRG20; adrenergic receptor, alpha 2a; Adrenergic alpha 2A receptor; Adrenergic, alpha 2A, receptor; alpha-2AAR; alpha-2A adrenoceptor; alpha-2A adrenoreceptor; alpha-2A adrenergic receptor; alpha-2D adrenergic receptor;
ADM2
adrenomedullin 2
ADM2;adrenomedullin 2;28898;ENSG00000128165;AM2;dJ579N16.4;22q13.33;FLJ21135;ADM2;ADM2;intermedin;
AJAP1
adherens junctions associated protein 1
AJAP1;adherens junctions associated protein 1;30801;ENSG00000196581;MOT8;SHREW1;SHREW-1;RP3-426F10.1;1p36.32;adherens junction-associated protein 1;adherens junction-associated protein 1;membrane protein shrew-1;transmembrane protein SHREW1;adherens junction associated protein 1;
DPEP1
dipeptidase 1 (renal)
DPEP1;dipeptidase 1 (renal);3002;ENSG00000015413;MDP;RDP;MBD1;16q24.3;dipeptidase 1;dipeptidase 1;hRDP;renal dipeptidase;dehydropeptidase-I;microsomal dipeptidase;EC 3.4.13.19;
EID2
EP300 interacting inhibitor of differentiation 2
EID2;EP300 interacting inhibitor of differentiation 2;28292;ENSG00000176396;CRI2;EID-2;19q13.2;MGC20452;EP300-interacting inhibitor of differentiation 2;EP300-interacting inhibitor of differentiation 2;CREBBP/EP300 inhibitor 2;CREBBP/EP300 inhibitory protein 2;E1A like inhibitor of differentiation 2;EID-1-like inhibitor of differentiation 2;
Slc6a2
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
SLC6A2;solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2;ENSMUSG00000055368;NET;NE-T;Slc6a5;8 C5;8 45.0 cM;sodium-dependent noradrenaline transporter;sodium-dependent noradrenaline transporter;NE transporter;norepinephrine transporter;solute carrier family 6 member 2;EC 2.3.1.5;
0610007C21Rik
all-trans retinoic acid induced differentiation factor
p18; Apr3; HSPC013; AI316792; 0610007C21Rik;
EID2B
EID2B EP300 interacting inhibitor of differentiation 2B [ Homo sapiens ]
EP300 interacting inhibitor of differentiation 2B; 26796; Ensembl:ENSG00000176401; FLJ38944; EP300-interacting inhibitor of differentiation 2B; EID-2B; EID-2-like inhibitor of differentiation 3; EID-2-like inhibitor of differentiation-3; EID-3;
GDAP1L1
GDAP1L1 ganglioside induced differentiation associated protein 1-like 1 [ Homo sapiens ]
ganglioside induced differentiation associated protein 1-like 1; 4213; Ensembl:ENSG00000124194; DKFZp761K228; ganglioside-induced differentiation-associated protein 1-like 1; GDAP1-L1; dJ881L22.1; dJ995J12.1.1;
PPDPF
PPDPF pancreatic progenitor cell differentiation and proliferation factor homolog (zebrafish) [ Homo sapiens ]
pancreatic progenitor cell differentiation and proliferation factor homolog(zebrafish); Exocrine differentiation and proliferation factor; C20orf149; hromosome 20 open reading frame 149; dJ697K14.9; pancreatic progenitor cell differentiation and proliferation factor; exdpf; EXPDF;
CD26
Cluster of Differentiation 26
ADA-binding protein; ADABP; ADCP 2; ADCP-2; ADCP2; Adenosine deaminase complexing protein 2; CD 26; CD26; CD26 antigen 3; Dipeptidyl peptidase 4; Dipeptidyl peptidase 4 soluble form; Dipeptidyl peptidase IV; Dipeptidyl peptidase IV membrane form; Dipeptidyl peptidase IV soluble form; Dipeptidylpeptidase 4; Dipeptidylpeptidase IV (CD26, adenosine deaminase complexing protein 2); Dipeptidylpeptidase IV; DPP 4; DPP IV; DPP IV estoenzyme; DPP4; DPP4_HUMAN; DPPIV; Intestinal dipeptidyl peptidase; T cell activation antigen CD26; T-cell activation antigen CD26; TP 103; TP103; cluster of differentiation 26;
CD64
Cluster of Differentiation 64
CD64; CD64 antigen; CD64A; Fc fragment of IgG high affinity Ia receptor; Fc fragment of IgG high affinity Ib receptor; Fc fragment of IgG high affinity Ic receptor; Fc fragment of IgG, high affinity Ia, receptor (CD64); Fc fragment of IgG, high affinity Ia, receptor; Fc fragment of IgG, high affinity Ib, receptor (CD64); Fc fragment of IgG, high affinity Ib, receptor; Fc fragment of IgG, high affinity Ic, receptor (CD64); Fc fragment of IgG, high affinity Ic, receptor; Fc gamma receptor; Fc gamma receptor I A1; Fc gamma receptor I; Fc gamma receptor I B2; Fc gamma RI; Fc of IgG high affinity Ia receptor; Fc-gamma RIC; FCG1; FcgammaRI; FCGR1; FCGR1A; FCGR1B; FCGR1C; FcRI; FCRIC; FLJ18345; High affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; IGFR1; IGFRB; IGFRC; IgG Fc receptor I; IgG Fc receptor IC; Immunoglobulin G Fc receptor I; Immunoglobulin G Fc receptor IB; Immunoglobulin G Fc receptor IC; MGC137713;
GDEP
GDEP gene differentially expressed in prostate [ Homo sapiens (human) ]
PCAN1; gene differentially expressed in prostate; Prostate cancer protein 1; GDEP;
Renaturation of Recombinant Proteins from Inclusion Bodies
Recombinant proteins expressed in bacteria often form inclusion bodies, especially when they are expressed at high levels. Creative BioMart retrieves expressed GST fusion protein in soluble form after lysis and extraction procedures. Advantages: Specifically for solubilizing and renaturing GST in...
Cell: A Promising Trend That Avoids Foreign Rejection and Replaces Damaged Neurons on self
This is a confocal micrograph of a primary human fibroblast cell grown in culture stained blue for actin, a highly abundant protein that makes up the cytoskeleton of cells. Mitochondria are shown in green. According to some statistics, it is estimated that 25% Americans will suffer from a neurode...
Industry Analysis: The Application and Development Trend of Recombinant Proteins
Recombinant proteins are manufactured by genetic engineering, cell engineering or other technologies, derived from organisms. Recombinant proteins have become one of the most products for current biology industry. From a broad range, recombinant proteins include recombinant proteins of na...
The Difference between Mouse Antibodies and Rabbit Antibodies
During past years, conventional antibodies have been widely utilized in researches, for example, protein detection via Western blot analyses, immunohistochemistry [1] and enzyme-linked immunosorbent assays (ELISA) [2] .And there are also newly developed technologies/antib...
Industrial-academic Cooperation Trend: A Good Way to Promote Biological Studies
In the past few years, research funds for bio-pharmaceutical industry have shown a downward trend. In order to get out of this predicament, pharmaceutical companies begin to seek opportunity to work with academic institutions to develop new drugs. Especially with the approaching of expiration of dru...
Drug Company Concern: Trend in Pharmaceutical Information
On January 3rd, the Public Accounts Committee, British House of Commons published a report with regard to the reservation issue of Tamiflu (a kind of influenza drug that is usually used in the treatment of both seasonal flu and swine flu), which sparked a discussion about...
The 4th International Conference on Biotechnology and Environment Management 2014
When September 15 to 16, 2014 Where Paris, France Introduction The 4th International conference on Biotechnology and Environment Management 2014 (ICBEM 2014) is a f...
The Biosimilar Industry Emerging Trends in Asia
At the time when biosimilars market development in the U.S. and Europe still looks a little hazy to analysts, and still many people are thinking over and surprising at how quickly these biologic knockoffs can muscle aside some powerhouse competition from well-known brands. In Asia, multi...
The Optimize 2013: Antibody Engineering & Discovery Conference
When 25 Feb. 2013 to 27 Feb. 2013 Where Maritim Hotel Frankfurt, Theodor-Heuss-Allee , Frankfurt, Germany Introduction With many antibody companies facing shared cha...
GTC 2013, Stem Cell Commercialization & Partnering conference
Introduction GTC's Stem Cell Commercialization Partnering conference, part of the 10th Stem Cell Summit, will be held on in Boston. This conference will present information regarding cutting-edge developments in all areas of stem cell research including Stem Cell, Induced Pluripotent Stem Ce...
2013 Asia Biotech Invest Conference
When 3rd June 2013 at 09:00 - 5th June 2013 at 17:00 Where Sheraton Hotel Towers, 20 Nathan Road, Kowloon, Hong Kong Introduction Organized by AusBiotech and Beacon Events, the conference is held in the financial hub Hong Kong. As the name suggests, the conference will bring cutt...
14th Annual G Protein-Coupled Receptor (GPCR) Retreat Conference
When Oct. 17th to 19th, 2013 Where 1260 Euclid Avenue, Cleveland,Ohio 44115 , United States Introduction The GPCRRetreat is an annual joint meeting that rotates ar...
Membrane Protein Structure and Function Conference
When May 13, 2013, till May 17, 2013 Where Suzhou Dushu Lake Conference Center, Suzhou, China Introduction The Cold Spring Harbor Asia Membrane Protein Structure and Function conference is organized by institutions such as University of Freiburg, Stanford University , University o...
2013 Sample Prep and Target Enrichment in Molecular Diagnostics Conference
When 10 Apr, 2013 to 11 Apr, 2013 Where Boston, MA, United States Introduction Sample preparation is important for research. Pre-detection processing is a pivotal part of molecular diagnostics. Its modernization should closely follow or even precede the emergence of new diagnostic...
The 2013 Bio Therapeutics Conference
2013 Euroscicon BioTherapeutics Week When May 14 to May 17, 2013 Where The Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage, UK Introduction Organized by Euroscicon, the event consists of four channels which all focus on the research, development and standardization ...
2013 Conference in Applied Bioinformatics & Public Health Microbiology
When May 15, 2013 to May 17, 2013 Where Moller Centre, Churchill College, Cambridge, UK Introduction Till now, the conference registration and abstract submission has closed. But the conference indeed accepts waitlist. Organized by Wellcome Trust, the conference aims to recent ...
5th International Conference on Crossroads between Innate and Adaptive Immunity
When Sep. 21, 2013 to Sep. 26, 2013 Where Grecotel Imperial Conference Center, Corfu, Greece Introduction Theme-based on immunology , the conference is organized by...
The 4th Annual Therapeutic Protein Production Conference
When 15th May, 2013 Where Gunnels Wood Road, Stevenage, Hertfordshire, United Kingdom Introduction This is a small conference. Organized by Euroscicon, the c...
The 23rd Neuropharmacology Conference 2013
The Synaptic Basis of Neurodegenerative Disorders When Nov. 7, 2013 and Nov. 8, 2013 Where Sheraton San Diego Hotel and Marina, San Diego, United States Introduction The conference focuses on neuroscience field. There is increasing evidence that neurodegenerative diseases have at their basis...
The 9th Annual International Conference on Predictive Human Toxicity and ADME/Tox Studies
The 9th Annual International Conference on Predictive Human Toxicity and ADME/Tox Studies 2014 ;will be held in Brussels, Belgium in January 2014. The exact time hasnt published yet. The conference dedicated to advances in predicting human toxicities and screening earlier in the drug discover...
The Market Trends of Elisa-kits
According to the GIA report, the US Research ELISA market is expected to reach $75 million by the year 2015. ELISA, or Enzyme-linked Immunosorbent Assay with the microtiter plate format, is a common technique for basic research and high through...
Drug Safety: the Glass Found in Ranbaxy's Generic Lipitor and Different Parties' Response
In terms of the foreign particles found in the glass-lined reactors at an active pharmaceutical ingredient plant in Toanasa, India in Nov. this year, Ranbaxy Laboratories' recall of generic Lipitor has spawned its first legal repercussion. Then the company notified FDA this fact and the foreign par...
Conference on 2013 Chromosomal-related
We are delight to introduce that our peer company Abcam will held the Chromatin, Replication and Chromosomal Stability 2013 conference to promote industry advance. The following are the related information: When From June 17 to June 19, 2013 Where Biotech Research Innovation Center (BRI...
2012 Trends and Highlights in Biology Industry
Whats the most popular in 2012 in biology industry? With the approaching of 2013, here the following we picked ten trends and highlights from the perspective of un-professional, let see them together: 1. Human Origins and Evolution: Several different studies highlight ongoing research on our earl...
The 5th Immunotherapeutics & Immunomonitoring Conference
When 31 Jan 2013 to 01 Feb 2013 Where The Westin Gaslamp Quarter, San Diego, United States Introduction Immunology is a broad branch of biomedica...
Methylation Interference Assay
Background and Principle Many cell related life processes involve the interaction between DNA and proteins. With the development of recombinant DNA technology, a wide range of critical genes have been isolated. Now the key issue is to reveal how environmental factors and developmental signals con...
Guide of Analysis of Differentially Expressed Proteins by Two-dimensional Electrophoresis
Two-dimensional electrophoresis refers to isoelectric focusing electrophoresis in the first direction and SDS-PAGE in the second direction. After the charge and relative molecular weight of the sample are separated twice, the isoelectric point and relative molecular weight of the molecule can be obt...
Principle and Protocol of Fluorescence Labeled Differential Analysis Gel Electrophoresis
Fluorescence-labeled differential analysis gel electrophoresis (2D-DIGE) is a new technique developed on the basis of two-dimensional electrophoresis to analyze protein expression differences. Compared with classical two-dimensional electrophoresis, it has higher sensitivity and accuracy, and can be...
